Hypercoagulability in non-transfusion-dependent thalassemia

Blood Reviews

Volumn 26, Issue SUPPL.1, 2012, Pages

  Cappellini, Maria D ^a   Musallam, Khaled M ^a   Poggiali, Erika ^a   Taher, Ali T ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Hypercoagulability; Hypercoagulable; Splenectomy; Thalassemia; Thromboembolism; Thrombosis; Transfusion

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FERRITIN; INTERCELLULAR ADHESION MOLECULE 1;

ARTICLE; BLOOD TRANSFUSION; BRAIN DAMAGE; CAUSAL ATTRIBUTION; DRUG USE; FERRITIN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; NON TRANSFUSIONAL DEPENDENT THALASSEMIA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SPLENECTOMY; THALASSEMIA; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS;

BETA-THALASSEMIA; BLOOD TRANSFUSION; HUMANS; RISK FACTORS; THROMBOPHILIA;

EID: 84861366756     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/S0268-960X(12)70007-3     Document Type: Article

References (25)

1. Eldor A, Rachmilewitz EA The hypercoagulable state in thalassemia. Blood 2002, 99(1):36-43.
2. Taher AT, Otrock ZK, Uthman I, Cappellini MD Thalassemia and hypercoagulability. Blood Rev 2008, 22(5):283-292.
3. Cappellini MD, Motta I, Musallam KM, Taher AT Redefining thalassemia as a hypercoagulable state. Ann N Y Acad Sci 2010, 1202:231-236.
4. Ataga KI, Cappellini MD, Rachmilewitz EA Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol 2007, 139(1):3-13.
5. Eldor A, Lellouche F, Goldfarb A, Rachmilewitz EA, Maclouf J In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 1991, 77(8):1749-1753.
6. Atichartakarn V, Angchaisuksiri P, Aryurachai K, Chuncharunee S, Thakkinstian A In vivo platelet activation and hyperaggregation in hemoglobinE/beta-thalassemia: a consequence of splenectomy. Int J Hematol 2003, 77(3):299-303.
7. Cappellini MD, Grespi E, Cassinerio E, Bignamini D, Fiorelli G Coagulation and splenectomy: an overview. Ann N Y Acad Sci 2005, 1054:317-324.
8. Kuypers FA, de Jong K The role of phosphatidylserine in recognition and removal of erythrocytes. Cell Mol Biol (Noisy-le-grand) 2004, 50(2):147-158.
9. Tavazzi D, Duca L, Graziadei G, Comino A, Fiorelli G, Cappellini MD Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes. Br J Haematol 2001, 112(1):48-50.
10. Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 1993, 44(1):63-65.
11. Atichartakarn V, Angchaisuksiri P, Aryurachai K, et al. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients. Br J Haematol 2002, 118(3):893-898.
12. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000, 111(2):467-473.
13. Taher A, Isma'eel H, Mehio G, et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost 2006, 96(4):488-491.
14. Borgna Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 1998, 99(2):76-79.
15. Taher AT, Musallam KM, Karimi M, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 2010, 115(10):1886-1892.
16. Musallam KM, Taher AT Thrombosis in Thalassemia: Why are we so Concerned?. Hemoglobin 2011, 35:503-510.
17. Gillis S, Cappellini MD, Goldfarb A, Ciceri L, Fiorelli G, Rachmilewitz EA Pulmonary thromboembolism in thalassemia intermedia patients. Haematologica 1999, 84(10):959-960.
18. Michaeli J, Mittelman M, Grisaru D, Rachmilewitz EA Thromboembolic complications in beta thalassemia major. Acta Haematol 1992, 87(1-2):71-74.
19. Wijburg FA, van den Berg W, van Teunenbroek A, Weening RS Thromboembolic complications after splenectomy in HbE-beta-thalassaemia. Eur JPediatr 1988, 147(4):444-445.
20. Manfre L, Giarratano E, Maggio A, Banco A, Vaccaro G, Lagalla R MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. AJR Am J Roentgenol 1999, 173(6):1477-1480.
21. Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun A Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. J Thromb Haemost 2010, 8(1):54-59.
22. Musallam KM, Beydoun A, Hourani R, et al. Brain magnetic resonance angiography in splenectomized adults with beta thalassemia intermedia. Eur JHaematol 2011, 87(6):539-546.
23. Taher AT, Musallam KM, Karimi M, et al. Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost 2010, 8(10):2152-2158.
24. Chen S, Eldor A, Barshtein G, et al. Enhanced aggregability of red blood cells of beta-thalassemia major patients. Am J Physiol 1996, 270(6 Pt 2):H1951-H1956.
25. Tripodi A, Cappellini MD, Chantarangkul V, et al. Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelas-tometry, but not by thrombin generation in platelet-poor plasma. Haematologica 2009, 94(11):1520-1527.